Key Initiatives

1
Key Initiatives

• Victorian Biotechnology Strategy 2004-2007
• Aim to be in top 5 biotech cities by 2010
• Over 500m committed to biotechnology
  initiatives
• Australian Synchrotron
• Kangaroo Genome Sequencing Project
• Australian Stem Cell Centre
• Victorian Partnership for Advanced Computing
• Centre for Pre-Clinical Drug Candidate
  Optimisation
• Nucleus Network
• National Neurosciences Facility
• Nanotechnology Victoria
• Bio21 Institute
• Graham Clarke Institute (formerly Bionic Ear
  Institute)
• RMIT Drug Discovery Technologies (RDDT)
• VESKI
• Bringing Australian expatriate scientists back
  to Australia

2
Drug Development Capabilities
Centre for Drug Candidate Optimisation
STC -
GxP Scale-Up MFG
Pre Clinical
Phase I
Phase II
Phase III
R D
Biopharmaceutical Formulation and Finishing
Sciences Centre
AMREP
3
Facts Figures

• Over 100 core biotech companies in Melbourne
• 43 stock market listed companies Market cap
  gt16billion
• 6,100 people employed by Vic biotech companies,
  30 emerging biotech companies, 70 established
  pharma
• 280m raised in last 12 months by Victorian
  Biotechs
• In excess of 500 clinical trials conducted across
  Melbourne institutions annually
• More than 20 specialist Medical Research
  institutes
• Home of discoveries such as Colony Stimulating
  Factors (GM-CSF), Neuraminidase inhibitors
  (Relenza)

4
Contacts

• Nucleus Network www.nucleusnetwork.com.au
• Andrew Giddy (a.giddy_at_nucleusnetwork.com.au)
• Lisa Nelson (l.nelson_at_centreforclinicalstudies.co
  m.au)
• Maria Chiam (m.chiam_at_nucleusnetwork.com.au)
• Maria is located in San Francisco PH 415- 544
  0958
• Invest Victoria www.invest.vic.gov.au
• David Brown (sanfrancisco_at_invest.vic.gov.au)
• BioMelbourne Network www.biomelbourne.org
• Tim Murphy (tmurphy_at_biomelbourne.org)
• Biotechnology Victoria www.biotechnology.vic.gov.a
  u
• Amanda Caples (amanda.caples_at_iird.vic.gov.au)